GXP-PHARMA SUPPORT ApS: Financial statements 2022
CVR: 36033347
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 211,195 and a net result of DKK -345,549 compared with DKK 425,670 the year before. That is a decrease of 80.7% compared with the year before. Equity in the 2022 report amounted to DKK 772,321. The solvency ratio was 69.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 211,195
- Profit/Loss
- DKK -345,549
- Equity
- DKK 772,321
- Total Assets
- DKK 1,104,592
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 211 t. | -346 t. | 772 t. | 1 |
| 2021 | - | 1.1 mio. | 426 t. | 1.1 mio. | 1 |
| 2020 | - | 1 mio. | 664 t. | 1.7 mio. | 1 |
| 2019 | - | 1.2 mio. | 328 t. | 1.4 mio. | - |
| 2018 | - | 1.5 mio. | 28 t. | 1.1 mio. | - |
Keep an eye on GXP-PHARMA SUPPORT ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GXP-PHARMA SUPPORT ApS has published its annual report for 2021. Gross profit came to DKK 1,094,653, and the net result was DKK 425,670.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The board consists of Jan Laursen (chair), Iben Cleveland Laursen and Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.